Enlivex Therapeutics Ltd. (ENLV) vs KALA BIO, Inc. (KALA)
A side-by-side comparison of Enlivex Therapeutics Ltd. and KALA BIO, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENLV
Enlivex Therapeutics Ltd.
$0.35HealthcareDelayed quote: Oct 6, 2026, 1:53 PM EDT
KALA
KALA BIO, Inc.
$0.37HealthcareDelayed quote: Oct 6, 2026, 1:51 PM EDT
Total return — ENLV vs KALA
growth of $100 · dividends reinvested · last 9yENLV -99.9% (-53.7%/yr)KALA -100.0% (-72.9%/yr)ENLV compounded faster over this window
Log scale — wide-divergence pair
ENLV KALA
ENLV vs KALA: by the numbers
- •KALA is the larger company ($7M vs $6M market cap).
Metrics side by side
Valuation
| Metric | ENLV | KALA |
|---|---|---|
| P/E ratio | 0.00 | N/A |
| P/B ratio | 0.00 | 0.78 |
Profitability
| Metric | ENLV | KALA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | 105.35% | -111.46% |
| ROIC | -0.32% | -232.05% |
Growth (annualized)
| Metric | ENLV | KALA |
|---|---|---|
| Total return CAGR (5Y) | -69.81% | -85.73% |
Frequently asked
- How have ENLV and KALA total returns compared?
- Over the past 5 years, ENLV delivered -69.81% and KALA delivered -85.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Enlivex Therapeutics ROEKALA BIO ROEEnlivex Therapeutics operating marginKALA BIO operating marginEnlivex Therapeutics revenue growthKALA BIO revenue growthEnlivex Therapeutics free cash flowKALA BIO free cash flow
Enlivex Therapeutics & KALA BIO appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.